United States (US) Bacteriophages Therapy Market (2025-2031) | Size & Revenue, Companies, Forecast, Growth, Value, Competitive Landscape, Industry, Share, Analysis, Trends, Segmentation, Outlook

Market Forecast By Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, Others), By Disease Indication (Urinary Tract Infections, Chronic Otitis, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, Others), By Route of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC9960584 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Bacteriophages Therapy Market Outlook
  • Market Size of United States (US) Bacteriophages Therapy Market, 2024
  • Forecast of United States (US) Bacteriophages Therapy Market, 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Revenues & Volume for the Period 2021- 2031
  • United States (US) Bacteriophages Therapy Market Trend Evolution
  • United States (US) Bacteriophages Therapy Market Drivers and Challenges
  • United States (US) Bacteriophages Therapy Price Trends
  • United States (US) Bacteriophages Therapy Porter's Five Forces
  • United States (US) Bacteriophages Therapy Industry Life Cycle
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Targeted Bacteria for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Escherichia coli for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Staphylococcus aureus for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Streptococcus for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Pseudomonas aeruginosa for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Salmonella for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Disease Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Urinary Tract Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Chronic Otitis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Chronic Ulcerative Colitis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Bone Infection for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Wound and Skin Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Cystic Fibrosis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Topical for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Bacteriophages Therapy Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • United States (US) Bacteriophages Therapy Import Export Trade Statistics
  • Market Opportunity Assessment By Targeted Bacteria
  • Market Opportunity Assessment By Disease Indication
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Bacteriophages Therapy Top Companies Market Share
  • United States (US) Bacteriophages Therapy Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Bacteriophages Therapy Company Profiles
  • United States (US) Bacteriophages Therapy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Bacteriophages Therapy Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Bacteriophages Therapy Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Bacteriophages Therapy Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Bacteriophages Therapy Market - Industry Life Cycle

3.4 United States (US) Bacteriophages Therapy Market - Porter's Five Forces

3.5 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F

3.6 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Bacteriophages Therapy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of antibiotic-resistant infections, driving the need for alternative therapies like bacteriophages.

4.2.2 Growing awareness and acceptance of bacteriophage therapy among healthcare professionals and patients.

4.2.3 Rising investments in research and development of bacteriophage-based treatments.

4.3 Market Restraints

4.3.1 Regulatory challenges and uncertainties surrounding the approval and commercialization of bacteriophage therapies.

4.3.2 Limited clinical data and standardized protocols for bacteriophage therapy, hindering widespread adoption.

4.3.3 Competition from established antibiotics and other antimicrobial therapies.

5 United States (US) Bacteriophages Therapy Market Trends

6 United States (US) Bacteriophages Therapy Market, By Types

6.1 United States (US) Bacteriophages Therapy Market, By Targeted Bacteria

6.1.1 Overview and Analysis

6.1.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F

6.1.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F

6.1.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F

6.1.5 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F

6.1.6 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F

6.1.7 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F

6.1.8 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Bacteriophages Therapy Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F

6.2.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F

6.2.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F

6.2.5 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F

6.2.6 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F

6.2.7 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F

6.3 United States (US) Bacteriophages Therapy Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F

6.3.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F

6.4 United States (US) Bacteriophages Therapy Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7 United States (US) Bacteriophages Therapy Market Import-Export Trade Statistics

7.1 United States (US) Bacteriophages Therapy Market Export to Major Countries

7.2 United States (US) Bacteriophages Therapy Market Imports from Major Countries

8 United States (US) Bacteriophages Therapy Market Key Performance Indicators

8.1 Number of clinical trials evaluating bacteriophage therapies in the US.

8.2 Adoption rate of bacteriophage therapy in US hospitals and healthcare facilities.

8.3 Investment trends in the US bacteriophage therapy market.

8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for bacteriophage therapy development.

9 United States (US) Bacteriophages Therapy Market - Opportunity Assessment

9.1 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F

9.2 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Bacteriophages Therapy Market - Competitive Landscape

10.1 United States (US) Bacteriophages Therapy Market Revenue Share, By Companies, 2024

10.2 United States (US) Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence